In conversation with Reid Hoffman & Robert F. Kennedy Jr.
2024-08-30 spoken.md · speaker-labeled ▶ watch ← E193 all episodes E195 →
Every number here is replayed from score_events — the same ledger the pool ranks on. Decay is what the 133 ideas nobody mentioned gave up this week; it applies only when an episode is processed.
Tier crossings
conviction thresholds crossed by this episode — 65 / 45 / 15 · ideas born here show where they landed. why 65 isn't always green
Kill dates that landed since E193
0 hit · 0 partial · 3 miss — windows that closed after 2024-08-23 and up to 2024-08-30, auto-scored against price data and never hand-set. verdict · R · α
| idea | verdict | R | α | closed |
|---|---|---|---|---|
| ⚡ Energy-transition capital flows under a national-security frame, not a climate frame | MISS | -34.0% | -63.5 | 2024-08-25 |
| 🤖 Nvidia's monopoly margins get competed away by custom and open silicon | MISS | -181.2% | -210.8 | 2024-08-25 |
| 📈 SoftBank is a forced seller — the Arm IPO is balance-sheet deleveraging | MISS | -31.7% | -61.2 | 2024-08-25 |
Who moved the board
each voice's force on conviction this episode — supports and opposes, weighted exactly as the replay applied them · share = % of this episode's movement
What got argued (14 ideas)
ordered by how hard each idea moved · quotes are verbatim from the transcript, timestamps deep-link into the episode
RFK Jr suspends his campaign, allies with Trump and is named a co-chair of the transition team with what he calls an understanding of co-governance on his three issues, the third being food, medicine and corruption at FDA/USDA/NIH. His named targets are ultra-processed food, commodity-agriculture subsidies, and the federal spend that funnels SNAP and school-lunch dollars into soda and processed food, plus the tobacco-company lineage of the big packaged-food brands. If Trump wins, the soda and packaged-food complex carries a real regulatory and reimbursement overhang rather than the zero policy risk it has priced for decades. Friedberg, Chamath and Sacks all endorse the diagnosis from different angles.
I mean, it's the three issues ending censorship, and that's pretty easy to do. You can do it with a series of executive orders, ending the Ukraine War, which is complex, but I think can be done very, very quickly. And then, you know, the food issue now, it's the food, it's medicine, it's corruption, and that regulatory agencies.
Well, I've already commented on the fish. The fish is outrageous, but there are ways to eat at a materially lower price than there is here, and the access to the ultra-processed food is different there. You can't get the stuff, and when you do find that stuff, it doesn't have the same glycemic and metabolic load on your body.
And it is again, $120 billion of annual federal spend with the biggest line item going to canned soda to feed 42 million Americans. And the connection is completely direct. High sugar, high glycemic index, diabetes, and other chronic health conditions arise from that connection.
everyone likes to talk about Google, I think the prime candidate is likely to be, and I'm speaking as an individual and as a venture capitalist here, is Apple with the App Store.
Reid Hoffman's read as a Microsoft board member and OpenAI's first commercial investor: Nvidia's sharp lead is specifically in chips for training clusters, but as demand scales the bulk of it moves to inference, where a wave of dedicated inference silicon arrives. Within one to two years Nvidia faces the choice of defending price and margin or responding to a competitive market, so the buildout stays intact for roughly two more years while the monopoly economics compress. The hedge inside the call is that Nvidia's position is strong enough that he would not recommend being short it.
But I do think that as you kind of scale the demand, there'll be a lot of inference chips coming in. You know, I think Chamath, you're invested in one of those. Oh, yeah. And I think there's going to be a bunch of those kind of coming in and the bulk of the demand will be on the inference side. And then Nvidia will have this challenge of, do I try to keep my prices and my margin? Or do I do what why we like competition? Do I have to respond to the competitive market? And then that, I think, will play out, you know, start playing out probably in a year, two at the latest, and then kind of go. So I think it's not sustain, the pure heat is not sustainable. But I think it's, you know, Nvidia has got a very strong position. And, you know, I definitely, I would recommend people not be short on Nvidia.
her theory is you got to prevent the aggregation of powers, you got to fight every acquisition of note. And the problem, of course, is that actually quells venture capital investment.
But that company's entire value is based upon the projections of what is going to sell in the United States. And that company is pouring tens of millions of dollars into lobbying to pass this bill that will make Medicare pay for it for every American who is obese.
And the European Commission has already openly censoring content, so they did not need to arrest him. They can take off whatever they want.
The 501c3 continues to control the mission and destiny and so forth. And so that question about its mission is still guiding things and you're essentially investing in that mission.
don't try to hold out for money on the training side of things, because we're going to create synthetic data, we're going to do all kinds of other things that are going to mean that no one's particular data is really going to matter. What you should be is on freshness, on brand, on other things
we're going to create synthetic data, we're going to do all kinds of other things that are going to mean that no one's particular data is really going to matter
Look, I think it's definitely a quelling impact, and it's definitely stupid, and definitely shouldn't happen.
We just had one of her top economic advisors come out on, I think it was CNBC defending it, and her campaign confirmed that she supports it. So now the argument has become, well, she supports it, it is really part of the platform. She would do it if she could, but she's not going to be able to do it.
we can train these models, like training is like reading. And like reading things is, like when something's available to be read, and you've engaged in the right economic thing for reading it, I think that's a kind of a reasonable, fair use thing.
let's rationalize the capital to when are we expecting revenue? How do we get revenue sooner to have that as a good productive cycle? How do we be not trying to just spend like drunken sailors, which is easy to do, but to be targeting business outcomes?
Episode digest
written during extraction and stored in data/extractions/ep194.json — the auditable source of truth, including everything market-adjacent that did not earn a capture
A two-guest interview episode: Reid Hoffman for roughly 75 minutes, then RFK Jr, with Reid staying on at Chamath's request. The real market content is Reid's, and it is genuinely new: Nvidia's lead is specifically in training clusters, the bulk of demand migrates to inference where a wave of inference chips arrives, and inside one to two years Nvidia must pick margin or share - though he would not be short it. He takes the direct other side of the pod's two standing AI theses, arguing Satya is rationalising capex to revenue rather than chasing a digital god, and telling news organisations not to hold out for training-data money because synthetic data means 'no one's particular data is really going to matter' - a clean oppose on both the training-data-owners and proprietary-data-is-the-moat threads. Reid, Sacks and Jason converge on Lina Khan chilling the base-hit M&A market, and Reid names Apple's App Store, not Google, as the prime antitrust candidate. On tax, Sacks pounds the 25% unrealized-gains and 44% capital-gains proposals with fresh receipts (her campaign and a CNBC-defending advisor), Reid concedes the tax is a quelling impact and stupid, and Chamath takes the other side that fringe proposals are sacrificial lambs that never pass. The RFK segment is mostly politics, but the food/pharma policy thread is tradeable: as a named Trump transition co-chair claiming co-governance on food, medicine and regulatory corruption, he targets ultra-processed food, commodity-ag subsidies and the SNAP/school-lunch soda spend, and calls Ozempic a pharma profit centre whose value rests on a Novo-lobbied Medicare bill. Friedberg, Chamath and Sacks all endorse pieces of the diagnosis. Pure politics - the five Trump cases, ballot-access lawfare, antisemitism, abortion - was skipped.